Condensed Consolidated Interim Statements of Income
for the six-month and three-month periods ended June 30, 2026 and 2025
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Six-months ended June 30, Three-months ended June 30,
Note 2026 2025 2026 2025
(unaudited)
Revenue | 4 | 929,691 | 707,586 | 531,011 | 382,080 |
Cost of revenue | 5 | (664,594) | (594,582) | (363,716) | (318,346) |
Initial recognition and changes in fair value of biological assets and agricultural produce | 15 | 25,491 | 33,093 | 1,588 | 9,531 |
Changes in net realizable value of agricultural produce after harvest | 2,764 | 2,560 | 5,902 | 1,337 | |
Margin on manufacturing and agricultural activities before operating expenses | 293,352 | 148,657 | 174,785 | 74,602 | |
General and administrative expenses | 6 | (74,944) | (70,967) | (39,119) | (38,686) |
Selling expenses | 6 | (111,763) | (76,752) | (58,785) | (39,606) |
Other operating income, net | 8 | 7,899 | 8,395 | 15,073 | 9,385 |
Profit from operations | 114,544 | 9,333 | 91,954 | 5,695 | |
Finance income | 9 | 110,957 | 43,357 | 8,777 | 6,957 |
Finance costs | 9 | (105,764) | (47,648) | (59,546) | (22,674) |
Other financial results - Net (loss) / gain of inflation effects on the monetary items | 9 | (13,195) | (5,317) | (6,521) | (5,727) |
Financial results, net | 9 | (8,002) | (9,608) | (57,290) | (21,444) |
Profit / (loss) before income tax | 106,542 | (275) | 34,664 | (15,749) | |
Income tax (expense) / benefit | 10 | (37,484) | 1,939 | (9,418) | (1,294) |
Profit / (loss) for the period | 69,058 | 1,664 | 25,246 | (17,043) | |
Attributable to: | |||||
Equity holders of the parent | 58,349 | 520 | 18,210 | (17,558) | |
Non-controlling interest | 10,709 | 1,144 | 7,036 | 515 |
Earnings per share attributable to the equity holders of the parent during the period: | ||||
Basic earnings/(loss) per share | 0.406 | 0.005 | 0.125 | (0.176) |
Diluted earnings/(loss) per share | 0.405 | 0.005 | 0.125 | (0.175) |
Condensed Consolidated Interim Statements of Comprehensive Income for the six-month and three-month periods ended June 30, 2026 and 2025
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Six-months ended June 30, Three-months ended June 30, 2026 2025 2026 2025
(unaudited)
Profit / (Loss) for the period | 69,058 | 1,664 | 25,246 | (17,043) |
Other comprehensive income: | ||||
Items that may be reclassified subsequently to profit or loss: | ||||
Exchange differences on translating foreign operations | 125,297 | 30,409 | (1,922) | (48,393) |
Items that will not be reclassified to profit or loss: | ||||
Revaluation surplus net of tax | (65,976) | (1,075) | 1,650 | 20,406 |
Other comprehensive income / (loss) for the period | 59,321 | 29,334 | (272) | (27,987) |
Total comprehensive income / (loss) for the period | 128,379 | 30,998 | 24,974 | (45,030) |
Attributable to: | ||||
Equity holders of the parent | 116,823 | 29,836 | 17,902 | (45,379) |
Non-controlling interest | 11,556 | 1,162 | 7,072 | 349 |
Condensed Consolidated Interim Statements of Financial Position as of June 30, 2026 and December 31, 2025
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Note | June 30, 2026 | December 31, 2025 | ||
(unaudited) | ||||
ASSETS | ||||
Non-Current Assets | ||||
Property, plant and equipment, net | 11 | 3,086,174 | 3,010,351 | |
Right of use assets | 12 | 354,803 | 388,993 | |
Investment property | 13 | 24,037 | 24,037 | |
Intangible assets, net | 14 | 256,840 | 253,875 | |
Biological assets | 15 | 44,980 | 40,488 | |
Deferred income tax assets | 10 | 24,386 | 23,722 | |
Trade and other receivables, net | 17 | 89,353 | 82,889 | |
Derivative financial instruments | 16 | 2,855 | 1,888 | |
Other Assets | 3,625 | 3,459 | ||
Total Non-Current Assets | 3,887,053 | 3,829,702 | ||
Current Assets | ||||
Biological assets | 15 | 231,953 | 274,256 | |
Inventories | 18 | 426,404 | 306,271 | |
Trade and other receivables, net | 17 | 372,026 | 364,350 | |
Derivative financial instruments | 16 | 403 | 1,243 | |
Short-term investments | 28,044 | 89,826 | ||
Cash and cash equivalents | 19 | 302,463 | 383,150 | |
Total Current Assets | 1,361,293 | 1,419,096 | ||
TOTAL ASSETS | 5,248,346 | 5,248,798 | ||
SHAREHOLDERS EQUITY | ||||
Capital and reserves attributable to equity holders of the parent | ||||
Share capital | 21 | 221,808 | 221,808 | |
Share premium | 21 | 841,643 | 876,091 | |
Cumulative translation adjustment | (343,144) | (426,225) | ||
Equity-settled compensation | 13,953 | 11,358 | ||
Other reserves | 150,753 | 153,237 | ||
Treasury shares | (5,344) | (7,940) | ||
Revaluation surplus | 251,102 | 275,709 | ||
Reserve from the sale of non-controlling interests in subsidiaries | 41,574 | 41,574 | ||
Retained earnings | 568,079 | 509,730 | ||
Equity attributable to equity holders of the parent | 1,740,424 | 1,655,342 | ||
Non-controlling interest | 138,156 | 136,949 | ||
TOTAL SHAREHOLDERS EQUITY | 1,878,580 | 1,792,291 | ||
LIABILITIES | ||||
Non-Current Liabilities | ||||
Trade and other payables | 23 | 719 | 700 | |
Borrowings | 24 | 1,577,679 | 1,379,921 | |
Lease liabilities | 25 | 260,665 | 296,643 | |
Deferred income tax liabilities | 10 | 716,067 | 728,634 | |
Payroll and social security liabilities | 26 | 821 | 567 | |
Derivatives financial instruments | 16 | 2,776 | 1,271 | |
Provisions for other liabilities | 27 | 23,507 | 22,269 | |
Total Non-Current Liabilities | 2,582,234 | 2,430,005 | ||
Current Liabilities | ||||
Trade and other payables | 23 | 197,785 | 673,160 | |
Current income tax liabilities | 10 | 41,861 | 31,921 | |
Payroll and social security liabilities | 26 | 41,425 | 38,782 | |
Borrowings | 24 | 440,037 | 213,088 | |
Lease liabilities | 25 | 56,305 | 59,959 | |
Derivative financial instruments | 16 | 5,279 | 4,123 | |
Provisions for other liabilities | 27 | 4,840 | 5,469 | |
Total Current Liabilities | 787,532 | 1,026,502 | ||
TOTAL LIABILITIES | 3,369,766 | 3,456,507 | ||
TOTAL SHAREHOLDERS EQUITY AND LIABILITIES | 5,248,346 | 5,248,798 |
for the six-month periods ended June 30, 2026 and 2025
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Attributable to equity holders of the parent
1,605
-
(1,605)
-
-
-
-
Granted
4,362
-
4,362
-
-
-
-
3,595
(19,496)
-
20,263
-
Employee share options (Note 22)
Restricted shares and restricted units (Note 22):
Vested
29,334
18
29,316
-
-
1,225
-
-
Balance at January 1, 2025 167,073 659,399 (413,757) 17,264 151,261 (16,989) 245,261 41,574 518,064 1,369,150 38,951 1,408,101
Other comprehensive income:
Revaluation of surplus (*) - - - - - - (1,545) - - (1,545) 470 (1,075)
Total comprehensive income for the period - - 28,091 - - - 1,225 - 520 29,836 1,162 30,998
Exercised - 52 - (15) - 8 - - - 45 - 45
Value of employee services - - - 13,454 - - - - - 13,454 - 13,454
Forfeited - - - - 2 (2) - - - - - -
-Purchase of own shares (Note 21) - (8,623) - - - (1,587) - - - (10,210) - (10,210)
Balance at June 30, 2025 (unaudited) 158,073 636,091 (385,666) 11,207 153,253 (7,965) 246,486 41,574 518,584 1,371,637 40,113 1,411,750
(35,000)
-
(35,000)
-
-
-
-
-
-
-
(35,000)
-
- Dividends to shareholders (Note 21)
-
-
-
-
-
-
Reserve from the sale of
Cumulative Translation Adjustment
Share Capital Share
(Note 21) Premium
30,409
(452)
30,861
-
-
2,770
-
-
-
28,091
-
Equity-settled Other Compensation reserves
Reduction of issued share capital of the company (Note 20):
(9,000)
-
-
-
-
9,000
-
-
-
-
-
-
-
-
28,091
-
-
- Items that will not be reclassified to profit or loss:
Other comprehensive income for the period
- Items that may be reclassified subsequently to profit or loss:
1,664
1,144
520
520
-
-
-
Exchange differences on translating foreign operations
-
-
-
-
Profit for the period
subsidiaries
Non- Total
Controlling Shareholders' Interest Equity
terests
Subtotal
Retained Earnings
non-
co ing
ntroll
in in
Treasury Revaluation
shares surplus
(*) Net of 417 of Income tax.
for the six-month periods ended June 30, 2026 and 2025 (continued)
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Attributable to equity holders of the parent
Subtotal
Reserve
Share Capital (Note 21)
Share Premium
Cumulative Translation Adjustment
Equity-settled Compensati on
Other reserves
Treasury shares
Revaluation surplus
from the sale of non-controlling interests in subsidiaries
Retained Earnings
Non-Controlling Interest
Total Shareholder s' Equity
Balance at January 1, 2026 221,808 876,091 (426,225) 11,358 153,237 (7,940) 275,709 41,574 509,730 1,655,342 136,949 1,792,291
Profit for the period - - - - - - - 58,349 58,349 10,709 69,058
Other comprehensive income / (loss):
- Items that may be reclassified subsequently to profit or loss:
Exchange differences on translating foreign operations - - 83,081 - - - 36,409 - - 119,490 5,807 125,297
- Items that will not be reclassified to profit or loss:
Revaluation surplus (*) - - - - - - (61,016) - - (61,016) (4,960) (65,976)
Other comprehensive income for the period - - 83,081 - - - (24,607) - - 58,474 847 59,321
Total comprehensive income for the period - - 83,081 - - - (24,607) - 58,349 116,823 11,556 128,379
- Employee share options (Note 22): | ||||||||||||
Exercised | - | 362 | - | (116) | - | 66 | - | - | - | 312 | - | 312 |
- Restricted shares and restricted units (Note 22): | ||||||||||||
Value of employee services | - | - | - | 2,925 | - | - | - | - | - | 2,925 | - | 2,925 |
Vested | - | 190 | - | (214) | 46 | - | - | - | - | 22 | - | 22 |
Granted | - | - | - | - | (2,530) | 2,530 | - | - | - | - | - | - |
- Dividends to shareholders (Note 21) | - | (35,000) | - | - | - | - | - | - | - | (35,000) | - | (35,000) |
- Dividends to non-controlling interest | - | - | - | - | - | - | - | - | - | - | (10,349) | (10,349) |
Balance at June 30, 2026 (unaudited) | 221,808 | 841,643 | (343,144) | 13,953 | 150,753 | (5,344) | 251,102 | 41,574 | 568,079 | 1,740,424 | 138,156 | 1,878,580 |
*) Net of 35,440 of Income tax. |
(
for the six-month periods ended June 30, 2026 and 2025
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Six-months ended June 30,
Note 2026 2025
(unaudited)
Cash flows from operating activities: | |||
Profit for the period | 69,058 | 1,664 | |
Adjustments for: | |||
Income tax expense / (benefit) | 10 | 37,484 | (1,939) |
Depreciation of property, plant and equipment | 11 | 137,360 | 81,752 |
Depreciation of right of use assets | 12 | 39,263 | 38,372 |
Net loss from the fair value adjustment of investment properties | 13 | 3,538 | (479) |
Amortization of intangible assets | 14 | 2,206 | 1,075 |
Gain from disposal of other property items | 8 | (1,930) | (408) |
Equity settled share-based compensation granted | 7 | 4,154 | 11,894 |
Loss / (gain) from derivative financial instruments | 8, 9 | 4,723 | (7,193) |
Interest, finance cost related to lease liabilities and other financial expense, net | 9 | 76,000 | 39,787 |
Initial recognition and changes in fair value of non-harvested biological assets (unrealized) | (19,124) | (6,159) | |
Changes in net realizable value of agricultural produce after harvest (unrealized) | (880) | (2,137) | |
Provision and allowances | (407) | 36 | |
Tax credit recognized | 8 | (7,758) | (3,419) |
Net loss of inflation effects on the monetary items | 9 | 13,195 | 5,317 |
Foreign exchange gains, net | 9 | (91,082) | (34,000) |
Subtotal | 265,800 | 124,163 | |
Changes in operating assets and liabilities: | |||
Increase in trade and other receivables | (29,289) | (100,002) | |
Increase in inventories | (85,479) | (52,824) | |
Decrease in biological assets | 91,978 | 113,599 | |
Decrease in other assets | 224 | 205 | |
Decrease / (increase) in derivative financial instruments | 5 | (1,843) | |
(Decrease) / increase in trade and other payables | (99,144) | 28,343 | |
Increase in payroll and social security liabilities | 1,774 | 1,101 | |
Increase in provisions for other liabilities | 1,057 | 90 | |
Net cash provided by operating activities before taxes paid | 146,926 | 112,832 | |
Income tax paid | (24,554) | (1,795) | |
Net cash provided by operating activities | (a) | 122,372 | 111,037 |
for the six-month periods ended June 30, 2026 and 2025 (continued)
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Six-months ended June 30,
Note 2026 2025
(unaudited)
Cash flows from investing activities: | |||
Acquisition of a business, net of cash and cash equivalents acquired | (401,832) | - | |
Purchases of property, plant and equipment | 11 | (141,510) | (137,681) |
Purchases of cattle and non-current biological assets | (27) | (2,542) | |
Purchases of intangible assets | 14 | (723) | (818) |
Interest received and others | 16,354 | 4,000 | |
Proceeds from sale of property, plant and equipment | 1,998 | 615 | |
Proceeds from sale of farmlands and other assets | - | 1,601 | |
Acquisition of short-term investment | 16 (b) | (104,750) | (72,767) |
Disposal of short-term investment | 16 | 179,250 | 84,868 |
Net cash used in investing activities | (c) | (451,240) | (122,724) |
Cash flows from financing activities: | |||
Proceeds from equity settled share-based compensation exercise | 312 | 45 | |
Proceeds from long-term borrowings | 24 | 367,278 | 27,547 |
Payments of long-term borrowings | (49,296) | (42,602) | |
Proceeds from short-term borrowings | 147,964 | 166,725 | |
Payment of short-term borrowings | (82,690) | (64,153) | |
(Payments) / proceeds of derivative financial instruments | (423) | 33 | |
Lease payments | (58,191) | (60,285) | |
Interest paid | (d) | (49,645) | (26,520) |
Purchase of own shares | - | (10,210) | |
Dividends paid to non-controlling interest | (10,155) | - | |
Dividends to shareholders | 21 | (17,500) | (17,500) |
Net cash generated in financing activities | (e) | 247,654 | (26,920) |
Net decrease in cash and cash equivalents | (81,214) | (38,607) | |
Cash and cash equivalents at beginning of period | 19 | 383,150 | 211,244 |
Effect of exchange rate changes and inflation on cash and cash equivalents | (f) | 527 | 7,970 |
Cash and cash equivalents at end of period | 19 | 302,463 | 180,607 |
Combined effect of IAS 29 and IAS 21 of the Argentine subsidiaries over: | 2026 | 2025 | |
Operating activities | (a) | (7,075) | 2,228 |
Acquisition of short term investment | (b) | 10,278 | (444) |
Investing activities | (c) | 9,779 | 758 |
Interest paid | (d) | 164 | (2,338) |
Financing activities | (e) | (530) | (4,654) |
Exchange rate changes and inflation on cash and cash equivalents | (f) | (2,174) | 1,668 |
For non-cash transactions, see Note 11 and 12 for property, plant and equipment and right of use assets, respectively.
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
General information
Adecoagro S.A. (the "Company" or "Adecoagro") is the Group's ultimate parent company and is a société anonyme (stock corporation) organized under the laws of the Grand Duchy of Luxembourg. Adecoagro is a holding company primarily engaged through its operating subsidiaries in agricultural and agro-industrial activities. The Company and its operating subsidiaries are collectively referred to hereinafter as the "Group." The Group's activities are carried out through three major lines of business, namely, Sugar, Ethanol and Energy, Fertilizers and Food and Agriculture.
As further described in Note 20, on December 18, 2025, the Group completed the acquisition of Profertil S.A. Accordingly, Profertil S.A. has been consolidated from the acquisition date. The condensed consolidated statement of income for the three and six-month periods ended June 30, 2026 and the condensed consolidated statement of cash flows for the six-month period ended June 30, 2026 include Profertil S.A. for the full interim period, while the comparative information for the six-month period ended June 30, 2025 does not include Profertil S.A. As a result, the condensed consolidated statement of income for three and six-month periods ended June 30, 2026 and the condensed consolidated statement of cash flows for the six-month period ended June 30, 2026 are not directly comparable with the corresponding 2025 periods. These condensed consolidated interim financial statements should be read in light of these circumstances and the related disclosure in Note 20.
Adecoagro is a public company listed in the New York Stock Exchange (NYSE) as a foreign registered company under the ticker symbol of AGRO.
These Interim Financial Statements have been approved for issue by the Board of Directors on August 7, 2026.
Financial risk management
Risk management principles and processes
The Group is exposed to several risks arising from financial instruments including price risk, exchange rate risk, interest rate risk, liquidity risk and credit risk. A thorough explanation of the Group's risks and the Group's approach to the identification, assessment and mitigation of risks is included in the annual consolidated financial statements. There have been no significant changes to the Group's exposure and risk management principles and processes since December 31, 2025. See Note 2 to the annual consolidated financial statements for more information.
However, the Group considers that the following tables below provide useful information to understand the Group's interim results for the six-month period ended June 30, 2026. These disclosures do not appear in any particular order of potential materiality or probability of occurrence.
Argentina status:
The Argentine subsidiaries of the Group operate in an economic context in which main variables have a strong volatility as a consequence of political and economic uncertainties, both in national and international environments. Argentina's inflation rate for the six-month period ended June 30, 2026 and 2025 were 16.8% and 15.1%, respectively. The Group uses Argentina's official exchange rate to account for transactions in Argentina, mainly affecting the food and agricultural business segment, which as of June 30, 2026 and 2025, respectively, was 1,482 and 1,205, respectively, against the U.S. dollar.
On December 10, 2023, a new government took office with the aim to boost a deregulation of the Argentine economy and other regulations. Certain regulations and/or restrictions have been eased and others remain in force, although it is expected that they will be lifted gradually. However, the scope and timing of the measures, including but not limited to the existing foreign exchange regulations, remains uncertain as of the date of these Consolidated Financial Statements.
The Argentine Central Bank, under the prior administration, had implemented certain measures that controlled and restricted the ability of companies and individuals to access the foreign exchange market known as MULC (for its acronym in Spanish) for certain transactions. However, the performance of blue-chip swap transactions known as "Contado con Liquidación" or CCL (for its acronym in Spanish) was an alternative lawful mechanism. The blue-chip swap transactions are capital markets
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Financial risk management (continued)
transactions that could be implemented in different ways, both for the inflow and outflow of funds. The implicit exchange rate applicable to this type of transactions is higher with respect to the official foreign exchange rate.
Through Central Bank Communication "A" 8226 and Decree 269/2025, implemented in April 2025, Argentina introduced certain measures aimed at liberalizing its foreign exchange market. These measures included allowing individuals to purchase U.S. dollars for savings purposes without prior authorization, provided that transactions are made through bank debit, enabling the repatriation of dividends related to financial statements from 2025 onwards, and allowing payments for services to unrelated foreign parties to be made immediately, with a reduced 90-day waiting period for related parties.
However, as of July 31, 2026, the complete removal of exchange controls has not yet materialized and several restrictions remain in force. The monetary policy framework has shifted to a managed floating exchange rate regime, under which the exchange rate bands are adjusted by the Central Bank based on recent monthly inflation data published by INDEC, rather than being expanded by a fixed 1% monthly rate. Despite the initial flexibilizations, legal entities remain prohibited from purchasing foreign currency for hoarding purposes. In addition, mandatory settlement requirements for foreign trade revenues within specific timeframes remain applicable, cross-restrictions continue to limit access to the official foreign exchange market for those operating in financial exchange markets such as MEP or CCL, and payments of financial debt between local subsidiaries and their foreign parent companies continue to be subject to limitations.
Exchange rate risk
The following tables show the Group's net monetary position broken down by various currencies for each functional currency in which the Group operates at June 30, 2026. All amounts are shown in US dollars.
June 30, 2026
(unaudited)
Functional currency
Peso
Net monetary position (Liability)/ Asset Argentine
Brazilian Reais
US Dollar Total
Argentine Peso | 81,633 | - | 20,669 | 102,302 |
Brazilian Reais | (1,769) | (624,142) | - | (625,911) |
US Dollar | (847,461) | (318,111) | (231,698) | (1,397,270) |
Uruguayan Peso | - | - | (5,089) | (5,089) |
Euro | - | - | (26,022) | (26,022) |
Total | (767,597) | (942,253) | (242,140) | (1,951,990) |
The Group's analysis shown on the tables below is carried out based on the exposure of each functional currency subsidiary against the U.S. Dollar. The Group estimated that, other factors being constant, a hypothetical 10% appreciation/ (depreciation) of the U.S. Dollar against the Brazilian real respective functional currencies for the period ended June 30, 2026 or the Uruguayan peso, or a 25% appreciation/(depreciation) of the U.S. Dollar against the Argentine peso.
June 30, 2026
(unaudited)
Functional currency
Peso
Net monetary position Argentine
Brazilian Reais
Chilean Peso
Total
US Dollar | (211,865) | (31,811) | 200 | (243,476) |
(Decrease) or increase in Profit before income tax | (211,865) | (31,811) | 200 | (243,476) |
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Financial risk management (continued)
Interest rate risk
The following table shows a breakdown of the Group's fixed-rate and floating-rate borrowings per currency denomination and functional currency of the subsidiary issuing the loans at June 30, 2026 (all amounts are shown in US dollars):
June 30, 2026
(unaudited)
Functional currency
Peso
Rate per currency denomination Argentine
Brazilian Reais
US
Dollar
Total
Fixed rate:
Brazilian Reais
-
131,042
-
131,042
US Dollar
214,228
339,073
1,081,605
1,634,906
Subtotal fixed-rate borrowings
214,228
470,115
1,081,605
1,765,948
Variable rate:
Brazilian Reais
-
223,215
-
223,215
Euro
-
-
28,553
28,553
Subtotal variable-rate borrowings
-
223,215
28,553
251,768
Total borrowings as per analysis
214,228
693,330
1,110,158
2,017,716
At June 30, 2026, if interest rates on floating-rate borrowings had been 1% higher (or lower) with all other variables held constant, Profit before income tax for the period would decrease as follows:
June 30, 2026
(unaudited)
Functional currency
Reais
Rate per currency denomination Brazilian US Dollar Total
Variable rate:
Brazilian Reais
(2,232)
-
(2,232)
Euro
-
(286)
(286)
Decrease in profit before income tax (2,232) (286) (2,518)
Credit risk
As of June 30, 2026, six banks accounted for approximately 70% of the total cash deposited (Credit Agricole, Itau, Rabobank, Santander, Max Capital and Banco do brasil).
Derivative financial instruments
The following table shows the outstanding positions for each type of derivative contract as of June 30, 2026:
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Financial risk management (continued)
Futures / Options
June 30, 2026
Type of
derivative contract
Quantities (thousands) (**)
Notional
amount
Market
Value Asset/
Profit / (Loss)
(*)
(unaudited)
(unaudited)
Futures:
Sale
Soybean
3
1,021
30
30
Sugar
26
9,785
369
(1,263)
Options:
Buy put
Sugar
24
75
75
(682)
Sell call
Sugar
69
(99)
(99)
(1,365)
Total
122
10,782
375
(3,280)
(Liability)
(*) Included in line "Gain / (Loss) from commodity derivative financial instruments" Note 8. (**) All quantities expressed in tons except otherwise indicated.
Commodity future contract fair values are computed with reference to quoted market prices on future exchanges.
Other derivative financial instruments
Floating-to-fixed interest rate swaps
The Group's subsidiary Adecoagro Vale do Ivinhema entered into interest rate swap operations:
In December 2020, with Itaú BBA in an aggregate amount of R$ 400 million. In these operations the company receives IPCA (Extended National Consumer Price Index) plus 4.24% per year, and pays CDI (an interbank floating interest rate in Reais) plus 1.85% per year. This swap was early terminated in December, 2025 and the subsidiary entered into a new interest rate swap operation with Itaú BBA in an aggregate amount of R$ 365 million. In this transaction, Adecoagro Vale do Ivinhema receives a fixed rate of 13.47% per annum and pays CDI (a floating interbank interest rate in Brazilian Reais) plus 0.05% per annum. This swap expires semiannually until December, 2034.
In July 2024 with:
Itaú BBA in an aggregate amount of R$ 76 million. In this operation the company receives IPCA (Extended National Consumer Price Index) plus 6.80% per year and pays CDI (an interbank floating interest rate in Reais) plus 0.49% per year. This swap expires in July 2034.
- BR Partners in an aggregate amount of R$ 115 million. In this operation the company receives IPCA (Extended National Consumer Price Index) plus 6.76% per year and pays CDI (an interbank floating interest rate in Reais) plus 0.41% per year. This swap expires in July 2031.
XP Investimentos in an aggregate amount of R$ 209 million. In this operation the Company receives pre-fixed rate 12.61% per year and pays CDI (an interbank floating interest rate in Reais) plus 0.48% per year. This swap expires in July 2031.
These interest rate swap agreements resulted in a recognition of a loss of US$ 4.2 million for the six-month period ended June 30, 2026.
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Financial risk management (continued)
Currency forward
No significant currency forward is in place.
Segment information
We are an agro-industrial company in South America, with operations in Argentina, Brazil and Uruguay. Our businesses encompass agricultural production, industrial processing and the production of critical agricultural inputs. In agriculture, we produce a diversified portfolio of products-including various crops, rice, sugarcane and dairy-supplying both our own industrial operations and third-party clients. Our manufacturing activities include the processing and commercialization of value-added products, such as sugar, ethanol, energy, processed peanuts, rice and dairy products, like UHT milk and powdered milk, among others. In addition, we produce nitrogen-based fertilizers, supporting agricultural productivity in Argentina and South America. We also provide ancillary services such as grain warehousing, conditioning, handling and drying. Furthermore, we opportunistically conduct land sales and/or acquisitions.
According to IFRS 8, operating segments are identified based on the 'management approach'. Operating segments are components of an entity about which separate financial information is available that is evaluated regularly by the chief operating decision maker ("CODM") in deciding how to allocate resources and in assessing performance. Our CODM is the Management Committee. IFRS 8 stipulates external segment reporting based on our internal organizational and management structure and on internal financial reporting to the chief operating decision maker.
Following the completion of the acquisition of Profertil S.A. on December 18, 2025 (see Note 20), and effective January 1, 2026, the Group's chief operating decision maker reassessed the Group's internal reporting structure and the manner in which operating performance is reviewed and resources are allocated. This reassessment resulted in the identification of a new Fertilizers segment, which comprises primarily the manufacturing and commercialization of nitrogen-based fertilizers.
In addition, effective January 1, 2026, we revised our segment reporting to reflect changes in the way we review operating performance and evaluate our business. As a result, our former farming activities are now presented as a single Food and Agriculture segment. The Food and Agriculture segment reflects an integrated business focused on the production and sale of food in various forms, including both raw agricultural outputs and manufactured food products. The Food and Agriculture segment includes the agricultural and related food activities that were previously managed and presented through separate verticals, including crops, rice and dairy. Beginning January 1, 2026, these activities are managed as one integrated value chain and evaluated based on overall segment operating performance. Accordingly, we evaluate results, make resource allocation decisions and assess profitability for the Food and Agriculture segment as a whole rather than based on separate operating results for the historical crops, rice or dairy verticals.
Consequently, comparative information has been recasted in the six-month period ended June 30, 2026, to conform the current presentation. Profertil has been consolidated since the acquisition date. Accordingly, the Group's consolidated statement of income for the six-month period ended June 30, 2026 includes Profertil's results of operations for the full interim period, while the consolidated statement of income for the six-month period ended June 30, 2025 does not include Profertil's results of operations. The Group reports the results of operations of the acquired business in the Fertilizers segment. Accordingly, the consolidated financial statements should be read in light of these circumstances.
Based on the foregoing, we operate in three reportable segments, namely, "Sugar, Ethanol and Energy", "Fertilizers" and , "Food and Agriculture".
'Sugar, Ethanol and Energy' segment which consists of cultivating sugarcane which is processed in owned sugar mills, transformed into ethanol, sugar and electricity and then marketed;
Segment information (continued)
The 'Fertilizers' segment consists of the production of nitrogen-based fertilizers, primarily urea, at our own industrial facility in Argentina, together with the commercialization of these products through a network of storage facilities spread across the country;
The 'Food and Agriculture' segment encompasses the Group's integrated agricultural operations, managed centrally as a single operating segment to maximize the overall use of land and resources. The segment's primary production activities consist of the planting, harvesting, and sale of crops-such as grains, oilseeds, and fibers (including soybeans, corn, wheat, peanuts, cotton, and sunflowers)-alongside the genetic development of seeds and cultivation of rice, and the production of raw milk in our own free-stalls. Following this primary phase, the segment's industrialization and service activities include the processing and commercialization of rice and other value-added products, the manufacturing of industrialized dairy goods (such as fluid milk, cheese, and powdered milk) within our own industrial facilities, and the provision of grain warehousing, conditioning, and drying services to third parties.
As further discussed in Note 32 to our consolidated financial statements for the year ended December 31, 2025, we apply IAS 29 to our operations in Argentina for those subsidiaries with the peso as its functional currency. According to IAS 29, all Argentine Peso-denominated non-monetary items in the statement of financial position are adjusted by applying a general price index from the date they were initially recognized to the end of the reporting period. Likewise, all Argentine Peso-denominated items in the statement of income are expressed in terms of the measuring unit current at the end of the reporting period, consequently, income statement items are adjusted by applying a general price index on a monthly basis from the dates they were initially recognized in the financial statements to the end of the reporting period. This process is called "re-measurement". Once the re-measurement process is completed, all Argentine Peso denominated accounts are translated into U.S. Dollars, which is our reporting currency, applying the guidelines in IAS 21 "The Effects of Changes in Foreign Exchange Rates" ("IAS 21"). IAS 21 requires that amounts be translated at the closing rate at the date of the most recent statement of financial position. This process is called "translation". The re-measurement and translation processes are applied on a monthly basis until year-end. Due to these processes, the re-measured and translated results of operations for a given month are subject to change until year-end, affecting comparison and analysis.
However, the internal reporting reviewed by the CODM departs from the application of IAS 29 and IAS 21 re-measurement and translation processes discussed above. For segment reporting purposes, the segment results of Argentine subsidiaries with the peso as its functional currency for each reporting period were adjusted for inflation and translated into the reporting currency using the reporting period average exchange rate. The translated amounts were not subsequently re-measured and translated in accordance with the IAS 29 and IAS 21 guidelines. In order to evaluate the segment's performance, results of operations in Argentina are based on monthly data adjusted for inflation and converted into the monthly US dollar average exchange rate. These converted amounts are not subsequently readjusted and reconverted as described under IAS 29 and IAS 21. It should be noted that this translation methodology for evaluating segment information is the same that the Group uses to translate results of operations from its other subsidiaries from other countries that have not been designated hyperinflationary economies because it allows for a more accurate analysis of the economic performance of its business as a whole. The CODM believes that the exclusion of the re-measurement and translation processes from the segment reporting structure allows for a more useful presentation and facilitates period-to-period comparison and performance analysis.
For all the Group's segments, the primary operating performance measure is "Profit or Loss from Operations" measured in accordance with the procedure outlined above. Total segment assets and liabilities are measured in a manner consistent with that of the Consolidated Financial Statements. These assets and liabilities are allocated based on the operations of the segment and the physical location of the asset.
The following tables show a reconciliation of the reportable segments information reviewed by our CODM with the reportable segment information measured in accordance with IAS 29 and IAS 21 as per the Consolidated Financial Statements for all periods presented. These tables do not include information for the Sugar, Ethanol and Energy nor Fertilizer reportable segments since this information is not affected by the application of IAS 29 and therefore there is no difference between the information reviewed by our CODM and the information included in the Consolidated Financial Statements:
Segment information (continued)
Segment reconciliation for the six-month period ended:
June 30, 2026 (unaudited) Food and Agriculture Corporate Total
Total segment reporting | Adjustment | Total as per statement of income | Total segment reporting | Adjustment | Total as per statement of income | Total segment reporting | Adjustment | Total as per statement of income | |
Revenue | 375,729 | 1,460 | 377,189 | - | - | - | 928,231 | 1,460 | 929,691 |
Cost of revenue | (343,216) | (1,562) | (344,778) | - | - | - | (663,032) | (1,562) | (664,594) |
Initial recognition and changes in fair value of biological assets and agricultural produce | 33,260 | 163 | 33,423 | - | - | - | 25,328 | 163 | 25,491 |
Changes in net realizable value of agricultural produce after harvest | 2,297 | (169) | 2,128 | - | - | - | 2,933 | (169) | 2,764 |
Margin on manufacturing and agricultural activities before operating expenses | 68,070 | (108) | 67,962 | - | - | - | 293,460 | (108) | 293,352 |
General and administrative expenses | (31,105) | (139) | (31,244) | (16,216) | (234) | (16,450) | (74,571) | (373) | (74,944) |
Selling expenses | (52,945) | (432) | (53,377) | (210) | (2) | (212) | (111,329) | (434) | (111,763) |
Other operating (expense) / income, net | (2,203) | (215) | (2,418) | 136 | (7) | 129 | 8,121 | (222) | 7,899 |
Profit / (loss) from operations | (18,183) | (894) | (19,077) | (16,290) | (243) | (16,533) | 115,681 | (1,137) | 114,544 |
Depreciation of Property, plant and equipment and amortization of Intangible assets | (21,041) | (260) | (21,301) | (817) | (12) | (829) | (139,294) | (272) | (139,566) |
Net gain from Fair value adjustment of Investment property | (3,369) | (169) | (3,538) | - | - | - | (3,369) | (169) | (3,538) |
Segment reconciliation for the six-month period ended:
June 30,2025 (unaudited) Food and Agriculture Corporate Total
Total segment reporting | Adjustment | Total as per statement of income | Total segment reporting | Adjustment | Total as per statement of income | Total segment reporting | Adjustment | Total as per statement of income | |
Revenue | 399,242 | (8,047) | 391,195 | - | - | - | 715,633 | (8,047) | 707,586 |
Cost of revenue | (353,617) | 7,427 | (346,190) | - | - | - | (602,009) | 7,427 | (594,582) |
Initial recognition and changes in fair value of biological assets and agricultural produce | 25,526 | (1,145) | 24,381 | - | - | - | 34,238 | (1,145) | 33,093 |
Changes in net realizable value of agricultural produce after harvest | 3,498 | (164) | 3,334 | - | - | - | 2,724 | (164) | 2,560 |
Margin on manufacturing and agricultural activities before operating expenses | 74,649 | (1,929) | 72,720 | - | - | - | 150,586 | (1,929) | 148,657 |
General and administrative expenses | (31,254) | 1,041 | (30,213) | (24,957) | 620 | (24,337) | (72,628) | 1,661 | (70,967) |
Selling expenses | (46,012) | 1,289 | (44,723) | (136) | 6 | (130) | (78,047) | 1,295 | (76,752) |
Other operating (expense) / income, net | 2,699 | (38) | 2,661 | (143) | 5 | (138) | 8,428 | (33) | 8,395 |
Profit / (loss) from operations | 82 | 363 | 445 | (25,236) | 631 | (24,605) | 8,339 | 994 | 9,333 |
Depreciation of Property, plant and equipment and amortization of Intangible assets | (18,125) | 596 | (17,529) | (870) | 30 | (840) | (83,453) | 626 | (82,827) |
Net loss from Fair value adjustment of Investment property | 479 | - | 479 | - | - | - | 479 | - | 479 |
3. Segment information (continued)
Fertilizers
Segment analysis for the six-month period ended June 30, 2026 (unaudited)
Sugar, Ethanol and Energy
Food and Agriculture
Corporate Total
Revenue | 256,729 | 295,773 | 375,729 | - | 928,231 |
Cost of revenue | (192,584) | (127,232) | (343,216) | - | (663,032) |
Initial recognition and changes in fair value of biological assets and agricultural produce | (7,932) | - | 33,260 | - | 25,328 |
Changes in net realizable value of agricultural produce after harvest | 636 | - | 2,297 | - | 2,933 |
Margin on manufacturing and agricultural activities before operating expenses | 56,849 | 168,541 | 68,070 | - | 293,460 |
General and administrative expenses | (14,569) | (12,681) | (31,105) | (16,216) | (74,571) |
Selling expenses | (32,980) | (25,194) | (52,945) | (210) | (111,329) |
Other operating (expense) / income, net | 3,993 | 6,195 | (2,203) | 136 | 8,121 |
Profit / (loss) from operations | 13,293 | 136,861 | (18,183) | (16,290) | 115,681 |
Depreciation of Property, plant and equipment and amortization of Intangible assets | (80,535) | (36,901) | (21,041) | (817) | (139,294) |
Net gain from Fair value adjustment of Investment property | - | - | (3,369) | - | (3,369) |
Initial recognition and changes in fair value of biological assets and agricultural produce (unrealized) | 11,441 | - | 7,275 | - | 18,716 |
Initial recognition and changes in fair value of biological assets and agricultural produce (realized) | (19,373) | - | 25,985 | - | 6,612 |
Changes in net realizable value of agricultural produce after harvest (unrealized) | - | - | 880 | - | 880 |
Changes in net realizable value of agricultural produce after harvest (realized) | 636 | - | 1,417 | - | 2,053 |
As of June 30, 2026: | |||||
Farmlands and farmland improvements, net | 89,249 | - | 642,130 | - | 731,379 |
Machinery, equipment, building and facilities, and other fixed assets, net | 264,641 | 1,183,678 | 289,941 | - | 1,738,260 |
Bearer plants, net | 455,911 | - | 1,382 | - | 457,293 |
Work in progress | 43,925 | 87,285 | 28,032 | - | 159,242 |
Right of use asset | 320,291 | 10,238 | 24,170 | 104 | 354,803 |
Investment property | - | - | 24,037 | - | 24,037 |
Goodwill | 4,219 | 208,204 | 17,892 | - | 230,315 |
Biological assets | 149,106 | - | 127,827 | - | 276,933 |
Finished goods | 60,874 | 85,441 | 85,861 | - | 232,176 |
Raw materials, Stocks held by third parties and others | 31,127 | 6,078 | 157,023 | - | 194,228 |
Total segment assets | 1,419,343 1,580,924 | 1,398,295 104 | 4,398,666 | ||
Borrowings | 647,356 | 985,218 | 385,142 | - | 2,017,716 |
Lease liabilities | 285,584 | 11,075 | 20,174 | 137 | 316,970 |
Total segment liabilities | 932,940 996,293 | 405,316 137 | 2,334,686 | ||
Segment information (continued)
Fertilizers
Segment analysis for the six-month period ended June 30, 2025 (unaudited)
Sugar, Ethanol and Energy
Food and Agriculture
Corporate Total
Revenue
316,391
-
399,242
-
715,633
Cost of revenue
(248,392)
-
(353,617)
-
(602,009)
Initial recognition and changes in fair value of biological assets and agricultural produce
8,712
-
25,526
-
34,238
Changes in net realizable value of agricultural produce after harvest
(774)
-
3,498
-
2,724
Margin on manufacturing and agricultural activities before operating expenses
75,937
-
74,649
-
150,586
General and administrative expenses
(16,417)
-
(31,254)
(24,957)
(72,628)
Selling expenses
(31,899)
-
(46,012)
(136)
(78,047)
Other operating (expense) / income, net
5,872
-
2,699
(143)
8,428
Profit / (loss) from operations
33,493
-
82
(25,236)
8,339
Depreciation of Property, plant and equipment and amortization of Intangible assets
(64,458)
-
(18,125)
(870)
(83,453)
Net loss from Fair value adjustment of Investment property
-
-
479
-
479
Initial recognition and changes in fair value of biological assets and agricultural produce (unrealized)
3,962
-
(102)
-
3,860
Initial recognition and changes in fair value of biological assets and agricultural produce (realized)
4,750
-
25,628
-
30,378
Changes in net realizable value of agricultural produce after harvest (unrealized)
-
-
2,137
-
2,137
Changes in net realizable value of agricultural produce after harvest (realized)
(774)
-
1,361
-
587
As of December 31, 2025:
Farmlands and farmland improvements, net
88,896
-
651,663
-
740,559
Machinery, equipment, building and facilities, and other fixed assets, net
245,119
1,218,881
254,611
-
1,718,611
Bearer plants, net
413,604
-
1,232
-
414,836
Work in progress
25,622
83,717
27,006
-
136,345
Right of use assets
352,466
9,208
26,788
531
388,993
Investment property
-
-
24,037
-
24,037
Goodwill
3,969
208,204
15,597
-
227,770
Biological assets
127,347
-
187,397
-
314,744
Finished goods
61,457
33,416
75,372
-
170,245
Raw materials, Stocks held by third parties and others
24,120
5,983
105,923
-
136,026
Total segment assets
1,342,600 1,559,409
1,369,626
531
4,272,166
Borrowings
570,737
711,099
205,771
105,402
1,593,009
Lease liabilities
324,888
9,895
21,118
701
356,602
Total segment liabilities
895,625 720,994
226,889
106,103
1,949,611
Revenue
The following tables show our various sources of revenue for the periods indicated:
Six-months ended June 30,
2026 | 2025 | |
(unaudited) | ||
Revenue of manufactured products and services rendered: | ||
Ethanol | 171,394 | 165,647 |
Sugar | 52,396 | 126,730 |
Energy (*) | 18,737 | 14,539 |
Urea | 250,301 | - |
Ammonia | 22,455 | - |
Peanut (*) | 25,297 | 32,387 |
Sunflower | 5,114 | 2,924 |
Cotton | 38 | 2,339 |
Rice | 94,786 | 116,107 |
Fluid milk (UHT) | 68,935 | 59,249 |
Powder milk | 24,530 | 20,815 |
Other dairy products | 40,651 | 42,953 |
Services | 5,592 | 4,725 |
Rental income | 886 | 461 |
Others | 44,756 | 26,975 |
Subtotal manufactured products and services rendered | 825,868 | 615,851 |
Agricultural produce and biological assets: | ||
Soybean | 50,713 | 40,549 |
Corn | 23,690 | 22,167 |
Wheat | 7,251 | 6,583 |
Rice | 6,925 | 628 |
Sunflower | 1,956 | 4,190 |
Barley | 1,896 | 1,977 |
Milk | 669 | 1,919 |
Cattle | 3,026 | 3,265 |
Cattle for dairy | 7,274 | 10,212 |
Others | 423 | 245 |
Subtotal agricultural produce and biological assets | 103,823 | 91,735 |
Total revenue | 929,691 | 707,586 |
(*) Includes revenue of mwh of energy and peanut produced by third parties for an amount of US$ 1.13 million and US$
0.24 million, respectively (June 30, 2025: revenue of mwh of energy produced by third parties for an amount of US$ 1.76 million).
Commitments to sell commodities at a future date
The Group entered into contracts to sell non-financial instruments, mainly, sugar, soybean and corn through sales forward contracts. Those contracts are held for purposes of delivery the non-financial instrument in accordance with the Group's expected sales. Accordingly, as the own use exception criteria are met, those contracts are not recorded as derivatives.
Notes to the Condensed Consolidated Interim Financial Statements (continued)
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Revenue (continued)
The notional amount of these contracts is US$ 113.8 million as of June 30, 2026 (June 30, 2025: US$ 113.2 million) comprised primarily of 6,782 liters of ethanol (US$ 3.65 million), 382,200 mwh of energy (US$ 17.92 million), 176,866 tons of sugar (US$ 61.07 million), 39,992 tons of soybean (US$ 15.71 million), 66,341 tons of corn (US$ 12.21 million), and 14,000 tons of wheat (US$ 3.08 million) which expire between December 2026 and May 2027.
Cost of revenue
The following tables show our cost of revenue for the periods indicated:
Total
Six-month ended June 30, 2026 (unaudited)
Sugar, Ethanol and Energy
Fertilizers
Food and Agriculture
Finished goods at the beginning of 2026 (Note 18)
61,457
33,416
75,372
170,245
Cost of production of manufactured products (Note 6)
192,675
154,203
260,981
607,859
Purchases
921
25,054
4,010
29,985
Agricultural produce
11,840
-
116,480
128,320
Transfer to raw material
-
-
(47,599)
(47,599)
Direct agricultural selling expenses
-
-
10,180
10,180
Tax recoveries (i)
(24,131)
-
-
(24,131)
Changes in net realizable value of agricultural produce after harvest
636
-
2,128
2,764
Loss of idle productive capacity
7,203
-
-
7,203
Finished goods as of June 30, 2026 (Note 18)
(60,874)
(85,441)
(85,861)
(232,176)
Exchange differences
2,857
-
9,087
11,944
Cost of revenue for the period
192,584
127,232
344,778
664,594
(i): Correspond to the presumed credit of ICMS (Imposto sobre Circulação de Mercadorias e Prestação de Serviços) over the sale values.
Six-month ended June 30, 2025 (unaudited)
Sugar, Ethanol and Energy
Food and Agriculture
Total
Finished goods at the beginning of 2025
94,633
93,521
188,154
Cost of production of manufactured products (Note 6)
172,825
258,284
431,109
Purchases
1,999
22,627
24,626
Agricultural produce
8,356
141,253
149,609
Transfer to raw material
-
(60,128)
(60,128)
Direct agricultural selling expenses
-
10,062
10,062
Tax recoveries (i)
(23,892)
-
(23,892)
Changes in net realizable value of agricultural produce after harvest
(774)
3,334
2,560
Loss of idle productive capacity
17,912
-
17,912
Finished goods as of June 30, 2025
(29,588)
(124,632)
(154,220)
Exchange differences
6,921
1,869
8,790
Cost of revenue for the period 248,392 346,190 594,582
(i): Correspond to the presumed credit of ICMS (Imposto sobre Circulação de Mercadorias e Prestação de Serviços) over the sale values.
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Expenses by nature
The following table provides the additional disclosure required on the nature of expenses and their relationship to the function within the Group:
Six-month ended June 30, 2026 (unaudited)
Total
Total
Cost of production of manufactured products (Note 5)
Sugar, Ethanol and Energy
Fertilizers
Food and Agriculture
General and Administrative Expenses
Selling Expenses
Salaries, social security expenses and employee benefits | 23,530 | 11,364 | 20,998 | 55,892 | 27,809 | 9,799 | 93,500 |
Raw materials and consumables | 4,146 | 82,287 | 21,685 | 108,118 | - | - | 108,118 |
Depreciation and amortization | 67,827 | 35,396 | 8,113 | 111,336 | 14,800 | 1,919 | 128,055 |
Depreciation of right-of-use assets | 6,423 | 167 | 113 | 6,703 | 10,597 | 74 | 17,374 |
Fuel, lubricants and others | 18,134 | - | 2,591 | 20,725 | 574 | 141 | 21,440 |
Maintenance and repairs | 15,729 | 6,415 | 5,475 | 27,619 | 2,649 | 1,616 | 31,884 |
Freights | 166 | 13,002 | 9,773 | 22,941 | - | 43,581 | 66,522 |
Export taxes / selling taxes | - | - | - | - | 329 | 29,357 | 29,686 |
Export expenses | - | 253 | - | 253 | - | 10,296 | 10,549 |
Contractors and services | 6,147 | 4,242 | 997 | 11,386 | 4,009 | 2,056 | 17,451 |
Energy transmission | - | - | - | - | - | 1,310 | 1,310 |
Energy power | 639 | - | 5,098 | 5,737 | 674 | 124 | 6,535 |
Professional fees | 323 | - | 195 | 518 | 5,673 | 424 | 6,615 |
Other taxes | 2,921 | - | 272 | 3,193 | 166 | 68 | 3,427 |
Contingencies | - | - | - | - | 755 | - | 755 |
Lease expense and similar arrangements | - | - | 749 | 749 | 1,310 | 387 | 2,446 |
Third parties raw materials | 7,331 | - | 45,731 | 53,062 | - | - | 53,062 |
Tax recoveries | (1,224) | - | - | (1,224) | - | - | (1,224) |
Others | 3,779 | 1,077 | 3,058 | 7,914 | 5,599 | 10,611 | 24,124 |
Subtotal | 155,871 | 154,203 | 124,848 | 434,922 | 74,944 | 111,763 | 621,629 |
Own agricultural produce consumed | 36,804 | - | 136,133 | 172,937 | - | - | 172,937 |
Total | 192,675 | 154,203 | 260,981 | 607,859 | 74,944 | 111,763 | 794,566 |
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Expenses by nature (continued)
Six-month ended June 30, 2025 (unaudited)
Cost of production of manufactured
Total
products (Note 5) General and
Selling
Sugar, Ethanol and Energy
Food and Agriculture
Administrati ve Expenses
Expenses Total
Salaries, social security expenses and employee benefits
19,061
20,432 39,493
28,254
7,131
74,878
Raw materials and consumables
2,118
22,865 24,983
-
-
24,983
Depreciation and amortization
48,754
5,732 54,486
13,094
763
68,343
Depreciation of right-of-use assets
5,145
39 5,184
10,553
36
15,773
Fuel, lubricants and others
13,256
1,922 15,178
481
132
15,791
Maintenance and repairs
12,488
5,684 18,172
3,773
470
22,415
Freights
242
7,974 8,216
(13)
33,669
41,872
Export taxes / selling taxes
-
- -
-
18,423
18,423
Export expenses
-
- -
-
7,049
7,049
Contractors and services
4,379
1,822 6,201
-
-
6,201
Energy transmission
-
- -
-
982
982
Energy power
451
4,703 5,154
336
124
5,614
Professional fees
457
160 617
9,162
320
10,099
Other taxes
3,922
248 4,170
664
100
4,934
Contingencies
-
- -
394
-
394
Lease expense and similar arrangements
-
947 947
852
442
2,241
Third parties raw materials
7,052
46,346 53,398
-
-
53,398
Tax recoveries
(2,270)
- (2,270)
-
-
(2,270)
Others
4,331
4,019 8,350
3,417
7,111
18,878
Subtotal
119,386
122,893 242,279
70,967
76,752
389,998
Own agricultural produce consumed
53,439
135,391 188,830
-
-
188,830
Total
172,825
258,284 431,109
70,967
76,752
578,828
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Salaries and social security expenses
Six-month period ended June 30, 2026 2025
(unaudited) | ||||
Wages and salaries | 103,364 | 79,725 | ||
Social security costs | 27,296 | 21,488 | ||
Equity-settled share-based compensation | 4,154 | 11,894 | ||
134,814 | 113,107 | |||
8. Other operating income expense, net | ||||
Six-month period ended June 30, | ||||
2026 | 2025 | |||
(unaudited) | ||||
(Loss) / gain from commodity derivative financial instruments | (699) | 3,014 | ||
Gain from disposal of other property items | 1,930 | 408 | ||
Net (loss) / gain from fair value adjustment of Investment property | (3,538) | 479 | ||
Tax credits recognized | 7,758 | 3,419 | ||
Others | 2,448 | 1,075 | ||
7,899 8,395
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Financial results, net
Six-month period ended June 30, 2026 2025
(unaudited)
Finance income:
- Interest income
14,925
4,121
- Foreign exchange gain, net
91,082
34,000
- Gain from interest rate/foreign exchange rate derivative financial instruments
-
4,731
- Other income
4,950
505
Finance income
110,957
43,357
Finance costs:
- Interest expense
(72,220)
(23,222)
- Finance cost related to lease liabilities
(18,410)
(19,999)
- Taxes
(5,691)
(3,199)
- Loss from interest rate/foreign exchange rate derivative financial instruments
(4,605)
-
- Other expenses
(4,838)
(1,228)
Finance costs
(105,764)
(47,648)
Other financial results - Net (loss) of inflation effects on the monetary items
(13,195)
(5,317)
Total financial results, net
(8,002)
(9,608)
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Taxation
Taxes on income in the interim periods are recognized using the tax rate that would be applicable to expected total annual earnings.
June 30, June 30,
2026 2025
(unaudited)
Current income tax | (56,261) | (3,433) |
Deferred income tax | 18,777 | 5,372 |
Income tax (expense) / benefit | (37,484) | 1,939 |
The gross movement on the deferred income tax liability is as follows:
June 30,
2026
(unaudited)
June 30,
2025
Beginning of period | (704,912) | (314,829) |
Exchange differences | (39,779) | (7,400) |
Effect of fair value valuation for farmlands | 35,440 | 417 |
Others | (1,207) | 3,138 |
Income tax benefit | 18,777 | 5,372 |
End of period | (691,681) | (313,302) |
The tax on the Group's profit before tax differs from the theoretical amount that would arise using the weighted average tax rate applicable to profits of the consolidated entities as follows:
June 30, June 30,
2026 2025
(unaudited)
Tax calculated at the tax rates applicable to profits in the respective countries | (38,045) | 1,445 |
Non-deductible items | (456) | (345) |
Non-taxable income | 6,007 | 4,547 |
Tax losses where no deferred tax asset was recognized | (6,113) | - |
Previously unrecognized tax losses now recouped to reduce tax expenses (1) | 578 | 4,638 |
Effect of IAS 29 on Argentina's shareholder's equity and deferred income tax. | 657 | (5,993) |
Impact of different functional and tax currencies | (899) | - |
Others | 787 | (2,353) |
Income tax (expense) / profit | (37,484) | 1,939 |
(1) 2026 includes 578 of adjustment by inflation of tax loss carryforwards in Argentina (2,270 in 2025). Tax Inflation Adjustment in Argentina |
The information of Tax Inflation Adjustment in Argentina which is described in detail in Note 10 to annual consolidated financial statements.
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Taxation (continued)
OECD Pillar Two model rules
The group is within the scope of the OECD Pillar Two model rules. Pillar Two legislation was enacted in Luxembourg, the jurisdiction in which Adecoagro S.A. is incorporated, and came into effect for the fiscal year starting on January 1st, 2024.
The group has not recognized Pillar Two current tax for the period ended June 30, 2026.
The group applies the IAS 12 exception to recognising and disclosing information about deferred tax assets and liabilities related to Pillar Two income taxes.
Adecoagro S.A.
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Property, plant and equipment, net
progress
Changes in the Group's property, plant and equipment for the six-month periods ended June 30, 2026 and 2025 were as follows:
Farmlands
Farmland improvements
Buildings and facilities
Machinery, equipment, furniture and Fittings
Bearer plants Others Work in
Total
Six-month period ended June 30 2025 | ||||||||
Opening net book amount. | 676,760 | 15,393 | 303,755 | 181,115 | 327,570 | 17,068 | 26,928 | 1,548,589 |
Exchange differences | 533 | (134) | 6,067 | 20,488 | 45,647 | (143) | 1,377 | 73,835 |
Additions | - | - | 4,878 | 24,721 | 65,056 | 2,352 | 27,405 | 124,412 |
Revaluation surplus | (1,485) | - | - | - | - | - | - | (1,485) |
Transfers | - | - | 9,033 | 2,769 | - | (167) | (11,635) | - |
Disposals | - | - | (796) | (1,048) | - | (50) | - | (1,894) |
Reclassification to non-income tax credits (*) | - | - | - | (140) | - | - | - | (140) |
Depreciation | - | (1,938) | (13,148) | (27,342) | (38,037) | (1,287) | - | (81,752) |
Closing net book amount | 675,808 | 13,321 | 309,789 | 200,563 | 400,236 | 17,773 | 44,075 | 1,661,565 |
At June 30, 2025 (unaudited) | ||||||||
Cost | 675,808 | 50,977 | 642,090 | 1,192,229 | 1,132,569 | 46,479 | 44,075 | 3,784,227 |
Accumulated depreciation | - | (37,656) | (332,301) | (991,666) | (732,333) | (28,706) | - | (2,122,662) |
Net book amount | 675,808 | 13,321 | 309,789 | 200,563 | 400,236 | 17,773 | 44,075 | 1,661,565 |
Six-month period ended June 30 2026 | ||||||||
Opening net book amount | 724,879 | 15,680 | 1,498,712 | 194,557 | 414,836 | 25,342 | 136,345 | 3,010,351 |
Exchange differences | 99,120 | 2,359 | 29,903 | 19,313 | 26,426 | 2,245 | 4,797 | 184,163 |
Additions | - | - | 5,648 | 26,867 | 59,152 | 461 | 43,157 | 135,285 |
Revaluation surplus | (101,415) | - | - | - | - | - | - | (101,415) |
Transfers | - | (3,900) | 20,488 | 7,746 | - | 723 | (25,057) | - |
Disposals | - | - | (1,690) | (3,056) | - | (16) | - | (4,762) |
Reclassification to non-income tax credits (*) | - | - | - | (88) | - | - | - | (88) |
Depreciation | - | (5,344) | (49,973) | (36,764) | (43,121) | (2,158) | - | (137,360) |
Closing net book amount | 722,584 | 8,795 | 1,503,088 | 208,575 | 457,293 | 26,597 | 159,242 | 3,086,174 |
At June 30, 2026 (unaudited) | ||||||||
Cost | 722,584 | 53,088 | 1,910,129 | 1,273,820 | 1,281,484 | 59,850 | 159,242 | 5,460,197 |
Accumulated depreciation | - | (44,293) | (407,041) | (1,065,245) | (824,191) | (33,253) | - | (2,374,023) |
Net book amount | 722,584 | 8,795 | 1,503,088 | 208,575 | 457,293 | 26,597 | 159,242 | 3,086,174 |
(*) Brazilian federal tax law allows entities to take a percentage of the total cost of the assets purchased as a tax credit. As of June 30, 2026, ICMS tax credits were reclassified to trade and other receivables.
The accompanying notes are an integral part of these condensed consolidated interim financial statements F- 26
Notes to the Condensed Consolidated Interim Financial Statements (continued)
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Property, plant and equipment, net (continued)
The Group determined the valuation of farmlands (US$ 723 million as of June 30, 2026) using, a "Sales Comparison Approach" prepared by an independent expert. Under the Sales Comparison Approach, the Group uses sale prices of comparable properties further adjusted considering the specific aspects of each property, the most relevant premise being the price per hectare (Level 3). The Group estimated that, other factors being constant, a 10% reduction on the sales price as of June 30, 2026 would have reduced the value of the farmlands by US$ 72.3 million, which would impact, net of its tax effect, the "Revaluation surplus" item in the statement of Changes in Shareholders' Equity.
Depreciation charges are included in "Cost of production of Biological Assets", "Cost of production of manufactured products", "General and administrative expenses", "Selling expenses", as appropriate, and/or capitalized in "Property, plant and equipment" for the six-month periods ended June 30, 2026 and 2025.
As of June 30, 2026, borrowing costs of US$ 3,032 (June 30, 2025: US$ 2,007) were capitalized as components of the cost of acquisition or construction of qualifying assets.
Right of use assets
Changes in the Group's right of use assets for the six-month periods ended June 30, 2026 and 2025 were as follows:
Agricultural partnership (*)
Others Total
(unaudited)
As of June 30, 2025
Opening net book amount
352,678
21,168
373,846
Exchange differences
41,012
3,834
44,846
Additions and re-measurement
16,832
7,419
24,251
Depreciation
(32,910)
(5,462)
(38,372)
Closing net book amount
377,612
26,959
404,571
As of June 30, 2026
Opening net book amount
355,187
33,806
388,993
Exchange differences
16,559
9,551
26,110
Additions and re-measurement
(21,596)
559
(21,037)
Depreciation
(32,179)
(7,084)
(39,263)
Closing net book amount
317,971
36,832
354,803
(*) Agricultural partnerships have an average term of 6 years.
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Investment property
Changes in the Group's investment property for the six-month periods ended June 30, 2026 and 2025 were as follows:
June 30, June 30,
2026 2025
(unaudited)
Beginning of period
24,037
33,542
(Loss) / gain from fair value adjustment (Note 8)
(3,538)
479
Exchange differences
3,538
(479)
End of period
24,037
33,542
Fair value
24,037
33,542
Net book amount
24,037
33,542
The Group determined the valuation of investment properties using a "Sales Comparison Approach" prepared by an independent expert. Sale prices of comparable properties are adjusted considering the specific aspects of each property, the most relevant premise being the price per hectare. (Level 3). The increase /decrease in the fair value is recognized in the Statement of income under the line item "Other operating income, net". There were no changes to the valuation techniques for any of the periods presented. The Group estimated that, other factors being constant, a 10% reduction on the Sales price as of June 30, 2026 would have reduced the value of the Investment properties on US$ 2.4 million, which would impact the line item "Net gain / (loss) from fair value adjustment."
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Intangible assets, net
Changes in the Group's intangible assets in the six-month periods ended June 30, 2026 and 2025 were as follows:
Goodwill
Software
Trademarks
Others
Total
As of June 30, 2025
Opening net book amount
20,242
7,162
9,256
571
37,231
Exchange differences
236
201
(72)
76
441
Additions
-
816
2
-
818
Amortization charge (i)
-
(822)
(251)
(2)
(1,075)
Closing net book amount
20,478
7,357
8,935
645
37,415
At June 30, 2025 (unaudited)
Cost
20,478
20,845
12,756
1,261
55,340
Accumulated amortization
-
(13,488)
(3,821)
(616)
(17,925)
Net book amount
20,478
7,357
8,935
645
37,415
As of June 30, 2026
Opening net book amount
227,770
17,179
8,295
631
253,875
Exchange differences
2,545
851
1,023
29
4,448
Additions
-
723
-
-
723
Amortization charge (i)
-
(1,930)
(274)
(2)
(2,206)
Closing net book amount
230,315
16,823
9,044
658
256,840
At June 30, 2026 (unaudited)
Cost
230,315
33,752
13,365
1,280
278,712
Accumulated amortization
-
(16,929)
(4,321)
(622)
(21,872)
Net book amount
230,315
16,823
9,044
658
256,840
Amortization charges are included in "General and administrative expenses" and "Selling expenses" for the period ended June 30, 2026 and 2025, respectively.
The Group conducts an impairment test annually or more frequently if events or changes in circumstances indicate that the carrying amount may not be recoverable. The last impairment test of goodwill was performed as of September 30, 2025.
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Biological assets
Changes in the Group's biological assets in the six-month periods ended June 30, 2026 and 2025 were as follows:
Sugarcane (i)
June 30, 2026 (unaudited) Food and
Agriculture (i) (ii)
Total
Beginning of year
127,347
187,397 314,744
Increase due to purchases
-
5,978 5,978
Initial recognition and changes in fair value of biological assets
(7,932)
33,423 25,491
Decrease due to harvest / disposals
(49,757)
(263,184) (312,941)
Costs incurred during the period
70,871
137,365 208,236
Exchange differences
8,577
26,848 35,425
End of period
149,106
127,827 276,933
June 30,
2025 (unaudited)
Sugarcane (i)
Food and Agriculture (i) (ii)
Total
Beginning of year
69,620
224,325
293,945
Increase due to purchases
-
2,542
2,542
Initial recognition and changes in fair value of biological assets
8,712
24,381
33,093
Decrease due to harvest / disposals
(64,369)
(317,035)
(381,404)
Costs incurred during the period
61,375
177,392
238,767
Exchange differences
9,840
(3,117)
6,723
End of period
85,178
108,488
193,666
Biological assets that are measured at fair value within level 3 of the hierarchy.
Biological assets that are measured at fair value within level 2 of the hierarchy
For those biological assets measured at fair value within level 3 of the fair value hierarchy, the Group uses valuation techniques based on unobservable inputs. This is only permissible insofar as no observable market data are available. The inputs used reflect the Group's assumptions regarding the factors, which market players would consider in their pricing. The Group uses the best available information for this, including internal company data
The discounted cash flow valuation technique and the significant unobservable inputs used to calculate the fair value of these biological assets are consistent with those described in Note 16 to of the consolidated financial statements for the year ended December 31, 2025.
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
15. Biological assets (continued)
Cost of production for the six-month period ended June 30, 2026:
Sugar, Ethanol and Energy
June 30, 2026
(unaudited)
Food and Agriculture
Total
Salaries, social security expenses and employee benefits | 9,255 | 15,214 | 24,469 |
Depreciation and amortization | 2,932 | - | 2,932 |
Depreciation of right-of-use assets | 17,822 | - | 17,822 |
Fertilizers, agrochemicals and seeds | 24,018 | 12,696 | 36,714 |
Fuel, lubricants and others | 3,391 | 2,195 | 5,586 |
Maintenance and repairs | 2,726 | 6,320 | 9,046 |
Freights | - | 3,463 | 3,463 |
Contractors and services | 8,619 | 32,076 | 40,695 |
Feeding expenses | - | 11,670 | 11,670 |
Veterinary expenses | - | 2,003 | 2,003 |
Energy power | - | 4,233 | 4,233 |
Professional fees | 165 | 391 | 556 |
Other taxes | 6 | 622 | 628 |
Lease expense and similar arrangements | 616 | 34,579 | 35,195 |
Others | 1,321 | 2,043 | 3,364 |
Subtotal | 70,871 | 127,505 | 198,376 |
Own agricultural produce consumed | - | 9,860 | 9,860 |
Total | 70,871 | 137,365 | 208,236 |
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Biological assets (continued)
Cost of production for the six-month period ended June 30, 2025:
Sugar, Ethanol and Energy
June 30, 2025
(unaudited)
Total
Food and Agriculture
Salaries, social security expenses and employee benefits
7,400
16,439
23,839
Depreciation and amortization
1,615
-
1,615
Depreciation of right-of-use assets
16,637
-
16,637
Fertilizers, agrochemicals and seeds
21,774
27,846
49,620
Fuel, lubricants and others
3,018
2,370
5,388
Maintenance and repairs
2,195
9,635
11,830
Freights
-
3,833
3,833
Contractors and services
6,724
33,886
40,610
Feeding expenses
-
12,432
12,432
Veterinary expenses
-
2,196
2,196
Energy power
-
3,782
3,782
Professional fees
188
722
910
Other taxes
34
635
669
Lease expense and similar arrangements
874
52,863
53,737
Others
916
1,792
2,708
Subtotal
61,375
168,431
229,806
Own agricultural produce consumed
-
8,961
8,961
Total
61,375
177,392
238,767
Biological assets as of June 30, 2026 and December 31, 2025 were as follows:
June 30,
2026
December 31,
2025
(unaudited)
Non-current
Cattle for dairy production
43,999
39,810
Breeding cattle
461
271
Other cattle
520
407
44,980
40,488
Current
Breeding cattle
20,987
14,325
Other cattle
1,258
937
Sown land - crops
43,776
51,384
Sown land - rice
16,826
80,263
Sown land - sugarcane
149,106
127,347
231,953
274,256
Total biological assets
276,933
314,744
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Financial instruments
As of June 30, 2026, the financial instruments recognized at fair value on the statement of financial position comprise derivative financial instruments.
For Level 1 instruments, valuation is based on the unadjusted quoted prices in active markets for identical financial assets that the Group can refer to at the date of the statement of financial position. A market is deemed active if transactions take place with sufficient frequency and in sufficient quantity for price information to be available on an ongoing basis. Since a quoted price in an active market is the most reliable indicator of fair value, this should always be used if available. Level 1 financial instruments mainly consist of crop futures and options traded on the stock market. In the case of securities, the Group allocates them to this level when either a stock market price is available or prices are provided by a price quotation on the basis of actual market transactions.
Derivatives not traded on the stock market are categorized as Level 2 instruments and are valued using models based on observable market data. The Group uses inputs directly or indirectly observable in the market, other than quoted prices. If the derivative financial instrument has a fixed contract period, the inputs used for valuation must be observable for the whole of this period. Level 2 financial instruments mainly consist of interest-rate swaps and foreign-currency interest-rate swaps.
For Level 3 instruments, the Group uses valuation techniques not based on inputs observable in the market. This is only permissible insofar as no observable market data are available. The inputs used reflect the Group's assumptions regarding the factors, which market players would consider in their pricing. The Group uses the best available information for this, including internal company data. The Group does not have any Level 3 financial instruments for any of the periods presented.
There were no transfers between any levels during any of the periods presented.
The following tables present the Group's financial assets and financial liabilities that are measured at fair value as of June 30, 2026 and their allocation to the fair value hierarchy:
2026 | |||||
Level 1 | Level 2 | Total | |||
Assets | |||||
Derivative financial instruments | 429 | 2,829 | 3,258 | ||
Short-term investment | 28,044 | - | 28,044 | ||
Total assets | 28,473 | 2,829 | 31,302 | ||
Liabilities | |||||
Derivative financial instruments | (28) | (8,027) | (8,055) | ||
Total liabilities | (28) | (8,027) | (8,055) | ||
The following table presents the Group's short term investment that are measured at fair value at June 30, 2026:
2026 | |
Corporate bonds | 26,390 |
Government securities | 1,654 |
Short-term investment | 28,044 |
When no quoted prices in an active market are available, fair values (particularly with derivatives) are based on recognized valuation methods. The Group uses a range of valuation models for this purpose, details of which may be obtained from the following table:
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
Financial instruments (continued)
Class
Pricing Method
Parameters
Pricing Model
Level
Total
Futures
Quoted price
-
-
1
399
Options
Quoted price
-
-
1
(24)
NDF
Quoted price
Foreign-exchange curve
Present value method
1
26
Interest-rate swaps
Theoretical price
Money market interest-rate curve.
Present value method
2
(5,198)
Public securities
Quoted price
-
-
1
28,044
Trade and other receivables, net
June 30,
2026
(unaudited)
December 31,
2025
Non-current | ||
Advances to suppliers | 43,273 | 37,183 |
Income tax credits | 8,865 | 8,516 |
Non-income tax credits (i) | 34,140 | 33,645 |
Judicial deposits | 2,269 | 2,070 |
Other receivables (ii) | 806 | 1,475 |
Non-current portion | 89,353 | 82,889 |
Current | ||
Trade receivables | 188,979 | 191,635 |
Less: Allowance for trade receivables | (4,357) | (4,782) |
Trade receivables - net | 184,622 | 186,853 |
Prepaid expenses | 27,620 | 21,014 |
Advance to suppliers | 62,581 | 43,994 |
Income tax credits | 17,358 | 11,847 |
Non-income tax credits (i) | 52,603 | 66,961 |
Receivables from related parties (Note 28) | 15,870 | 16,359 |
Other receivables | 11,372 | 17,322 |
Subtotal | 187,404 | 177,497 |
Current portion | 372,026 | 364,350 |
Total trade and other receivables, net | 461,379 | 447,239 |
(i) Includes US$ 88 for the six-month period ended June 30, 2026 reclassified from property, plant and equipment (for the year ended December 31, 2025: US$ 326).
Notes to the Condensed Consolidated Interim Financial Statements (continued)
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
17. Trade and other receivables, net (continued)
The fair values of current trade and other receivables approximate their respective carrying amounts due to their short-term nature. The fair values of non-current trade and other receivables approximate their carrying amount, as the impact of discounting is not significant.
The carrying amounts of the Group's trade and other receivables are denominated in the following currencies (expressed in US dollars):
June 30, 2026 | December 31, 2025 | ||
(unaudited) | |||
Currency | |||
US Dollar | 203,346 | 216,969 | |
Argentine Peso | 118,956 | 110,097 | |
Uruguayan Peso | 1,171 | 2,289 | |
Brazilian Reais | 137,906 | 117,884 | |
461,379 | 447,239 |
As of June 30, 2026 trade receivables of US$ 34,876 (December 31, 2025: US$ 36,576) were past due but not impaired. The ageing analysis of these receivables indicates that US$ 7,468 and US$ 3,985 are over 6 months in June 30, 2026 and December 31, 2025, respectively.
The creation and release of allowance for trade receivables have been included in 'Selling expenses' in the statement of income. Amounts charged to the allowance account are generally written off, when there is no expectation of recovering additional cash.
The other classes within other receivables do not contain impaired assets.
The maximum exposure to credit risk at the reporting date is the carrying value of each class of receivable mentioned
above. | |||
18. Inventories | |||
June 30, 2026 | December 31, 2025 | ||
(unaudited) | |||
Raw materials | 194,228 | 136,026 | |
Finished goods (Note 5) | 232,176 | 170,245 | |
426,404 | 306,271 | ||
19. Cash and cash equivalents | |||
June 30, 2026 | December 31, 2025 | ||
(unaudited) | |||
Cash at bank and on hand | 105,561 | 202,506 | |
Short-term bank deposits | 196,902 | 180,644 | |
302,463 | 383,150 | ||
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
20. Acquisitions (continued)
Acquisition of Profertil S.A.
On December 10, 2025, the Group acquired from Nutrien Ltd. ("Nutrien") its 50% interest in Profertil S.A. ("Profertil"). The acquisition was executed through a holding subsidiary formed together with a third-party, Asociación de Cooperativas Argentinas ("ACA"), with an 80%-20% ownership structure, respectively. The remaining 50% in Profertil was held by YPF S.A. ("YPF"). The total consideration for the transaction was US$596.3 million which were paid in cash by us and ACA on a proportionate basis. The Company incurred $3.2 million in transaction-related costs. The acquisition was accounted for under the equity method in accordance with IAS 28. Transaction costs were considered part of the cost of the investment at acquisition date.
On December 18, 2025, the Group acquired from YPF the remaining 50% interest it held in Profertil for a total consideration of US$596.3 million. The acquisition was carried out without the participation of ACA. As of June 30, 2026, it was fully paid.
The Group has accounted for the Acquisition under the purchase method of accounting in accordance with IFRS 3. Accordingly, the Group has made the allocation of the purchase price to the assets acquired and liabilities assumed based on their fair values at acquisition date. Goodwill is measured as the excess of the aggregate of consideration transferred, non controlling interest and fair value of previously held interest over the net identifiable assets acquired and liabilities assumed measured at fair value.
The approval of the Argentine Antitrust Authority is still pending.
The Company has made an allocation of the purchase price to the identifiable assets acquired and liabilities assumed based on their fair values at acquisition date. The Company has made significant assumptions and estimates in determining the purchase price, including the allocation of the purchase price in these consolidated financial statements.
The following table summarizes the fair value of purchase consideration, fair value of the previously held interest in Profertil and non controlling interest in Profertil:
Purchase consideration:
Amount paid in cash | 200,000 |
Amounts to be paid in installments | 396,282 |
Total purchase consideration | 596,282 |
Fair value of previously held interest in Profertil before the business combination | 476,847 |
Non-controlling interest | 95,829 |
Total | 1,168,958 |
Notes to the Condensed Consolidated Interim Financial Statements
(All amounts in US$ thousands, except shares and per share data and as otherwise indicated)
20. Acquisitions (continued)
The following table reflects the fair value of the net assets acquired:
Cash and cash equivalents | 1,007 |
Trade and other receivables | 159,010 |
Short-term investments | 38,688 |
Inventories | 50,286 |
Right of use assets | 9,221 |
Property, plant and equipment (*) | 1,303,071 |
Intangible assets | 10,419 |
Total Assets | 1,571,702 |
Trade and other payables | (63,304) |
Payroll and other liabilities | (7,039) |
Borrowings | (80,151) |
Lease liabilities | (9,904) |
Deferred income tax liabilities | (386,344) |
Current income tax liabilities | (41,462) |
Provision for other liabilities | (22,744) |
Total Liabilities | (610,948) |
Net identifiable Assets Acquired | 960,754 |
Add: goodwill | 208,204 |
Net assets acquired | 1,168,958 |
(*) Includes US$1,107 million related to the fertilizer plant complex of Bahia Blanca (Fertilizer Complex). |
The Group used a depreciated replacement cost approach to measure the fair value of property, plant and equipment, including the fertilizer plant complex. Under the cost approach, the value is based on the cost of a market participant to reconstruct a substitute asset of comparable utility, adjusted for any obsolescence. The key judgment and assumptions used include the current replacement cost and physical deterioration factors, including economic useful life and effective age. As a corroborative procedure, an income approach was also performed to assess the reasonableness of the results obtained under the cost approach. Determining the fair value of property, plant and equipment requires significant management judgment and involves the use of significant estimates and assumptions. The valuation was performed with the assistance of an independent valuation specialist.
The fair value of inventory was determined based on the estimated selling price in the ordinary course of business less the estimated costs of completion and sale, and an appropriate profit margin based on the effort required to complete and sell the inventories.
The fair value of long-term debt was estimated using a discounted cash flow analysis based on current market interest rates for debt instruments with similar terms, maturity and credit risk.
All other net tangible assets were valued at their respective carrying amounts, as management believes that these amounts approximate their current fair values.
The non-controlling interest was measured at its proportionate value the NCI's proportionate share of the acquiree's identifiable net assets.
A decrease in the fair value of assets acquired, or an increase in the fair value of liabilities assumed, compared to the preliminary valuations would result in a corresponding increase in the amount of goodwill. Conversely, an increase in the fair
Acquisitions (continued)
value of identifiable assets acquired would reduce goodwill. To the extent that adjustments relate to depreciable or amortizable assets, such changes would also affect future depreciation or amortization expense.
Goodwill is primarily attributable to expected synergies from expanding our agro-industrial platform and further diversify our revenue base. The goodwill is not deductible for tax purposes.
Profertil has been consolidated since the acquisition date. Accordingly, the Group's consolidated statement of income for the six-month period ended June 30, 2026 includes Profertil's results of operations for the full interim period, while the consolidated statement of income for the six-month period ended June 30, 2025 does not include Profertil's results of operations. The Group reports the results of operations of the acquired business in the Fertilizers segment. See Note 3 - "Segment information" for details.
Shareholder's contribution
Number of shares (thousands)
Share capital and share premium
At January 1, 2025 | 111,382 | 826,472 |
Reduction of issued share capital of the company | (6,000) | (9,000) |
Employee share options exercised (Note 22) | - | 52 |
Restricted shares vested | - | 20,263 |
Purchase of own shares | - | (8,623) |
Dividends to shareholders | - | (35,000) |
At June 30,2025 (unaudited) | 105,382 | 794,164 |
At January 1, 2026 | 147,872 | 1,097,899 |
Employee share options exercised (Note 22) | - | 362 |
Restricted share vested | - | 190 |
Dividends to shareholders | - | (35,000) |
At June 30,2026 (unaudited) | 147,872 | 1,063,451 |
Share capital issuance
On December 11, 2025, the Company completed a public offering of its common shares on the New York Stock Exchange. The Company issued 41,379,311 shares at a price of US$7.25 per share. In addition, on December 17, 2025, the Company issued 1,111,035 additional shares at a price of US$7.25 per share following the exercise by the underwriters of their over-allotment option. The offering resulted in aggregate gross proceeds of approximately US$308.0 million. Issuance costs related to the offering amounted to US$4.37 million.
As of June 30, 2026, the Company's issued share capital amounted to $221,808,241.50, represented by 147,872,161 shares in issue with a nominal value of US$1.50 each. Of these shares, 3,564,195 were held in treasury and 144,307,966 were outstanding as of June 30, 2026.
Decision of the Extraordinary General Shareholders' meetings
On June 6, 2025, the extraordinary general meeting of the shareholders of the Company resolved to reduce the issued share capital of the Company by US$9.0 million through the cancellation of 6,000,000 treasury shares with a nominal value of US$1.50 each. As a result, as from June 6, 2025, the Company's issued share capital amounted to US$158,072,722.50, represented by 105,381,815 shares in issue with a nominal value of US$1.50 each.
Shareholder's contribution (continued) Share Repurchase Program
On September 24, 2013, the Board of Directors of the Company has authorized a share repurchase program for up to 5% of its outstanding shares. The repurchase program has commenced on September 24, 2013 and is reviewed by the Board of Directors after each 12-month period. On December 11, 2024, the Board of Directors approved the renewal of the program, and also its extension for an additional twelve-month period, ending December 31, 2025. No further extension was approved.
As of June 30, 2026, the Company repurchased an aggregate of 32,299,783 shares under the program, of which 11,873,388 have been utilized to cover the exercise of the Company's employee stock option plan and the granted of the restricted stock plan and 11 million shares were reduced from capital. During the six-month periods ended June 30, 2026 and 2025 the Company repurchased shares for an amount of nil and 1,057,858 respectively.
Annual dividends
On April 16, 2026, the Company's general shareholders' meeting approved the payment of an annual dividend of
$35 million payable in two installments on May, 2026 and November, 2026, respectively. First installment was already paid.
On June 17, 2025, the Company's general shareholders' meeting approved the payment of an annual dividend of
$35 million payable in two installments in May 16, 2025 and November 19, 2025, respectively.
Net assets
The carrying amount of the net assets of the Company as of June 30, 2026 was USD 1.74 billions, which exceeds the Market Capitalization as of that date. This situation could mean that there is an impairment indicator as referred in IAS 36. A calculation of the value in use of net assets of the Company was made, through a discounted cash flow projections of the three major lines of business, Sugar, Ethanol and Energy, Fertilizers and Food and Agriculture based on financial forecast approved by the management covering a five-year period. The Company reached to the conclusion that no impairment should be recognized given the value in use of the Company determined is higher that its net assets book value as of June 30, 2026.
Equity-settled share-based payments
In 2004, the Group established the "2004 Incentive Option Plan" ("Option Schemes") under which the Group granted equity-settled options to senior managers and selected employees of the Group's subsidiaries.
Further, in 2010, the Group established the "Adecoagro Restricted Share and Restricted Stock Unit Plan" (the "Restricted Share Plan") under which the Group grants restricted shares, or restricted stock units to directors of the Board, senior and medium management and key employees of the Group.
Option Schemes
No expense was accrued for both periods under the Options Schemes.
As of June 30, 2026, 44,256 options (June 30, 2025: 5,149) were exercised. No options were forfeited or expired for any of the periods presented.
Restricted Share and Restricted Stock Unit Plan
On April 1, 2025, and as a consequence of the Possible acquisition as of that date, from Tether Investment S.A. de C.V. of the controlling interest of the Company, it was decided, as specified in the plan for a circumstance like this, an acceleration of the vesting of all granted restricted shares. As of June 30, 2026, the Group recognized compensation expense of US$ 3.8 million related to the restricted shares granted under the Restricted Share Plan (June 30, 2025: US$ 14.7 million). For the six-month period ended June 30, 2026, 1,686,924 Restricted Shares were granted (June 30, 2025: 1,069,913), 24,874 were vested (June 30,
2025: 2,406,118), and nil Restricted shares were forfeited (June 30, 2025: 1,541).

